#NNPA BlackPress
Drug Used to Treat Diabetes Now a Weight Loss Miracle but Difficult to Obtain in Black and Brown Communities
NNPA NEWSWIRE — In early 2022, Ozempic rose to fame when celebrities who do not suffer from diabetes began publicizing the drugs’ ability to assist in fast acting weight loss. It quickly went from a lifesaving medication for diabetics to the celebrity go to for shedding unwanted pounds. In 2021, in the US alone, prescriptions of the drug quadrupled landing the miracle drug on the worldwide shortage list creating rippling effects through many communities.
The post Drug Used to Treat Diabetes Now a Weight Loss Miracle but Difficult to Obtain in Black and Brown Communities first appeared on BlackPressUSA.

Small pharmacies find difficulty in prescribing the drug due to Big Pharma restrictions
By Andre ‘M. Johnson
According to a recent study published in Lucent, the number of people living with diabetes worldwide is on pace to more than double in the next three decades. This increase will bring the total of worldwide diabetic patients to a staggering 1.3 billion by 2025, making diabetes one of the top 10 leading causes of death and disability, in the world.
On December 5th of 2017, a little-known drug hit the market to help millions of people suffering with diabetes. The drug was called Ozempic. Ozempic was created to lower blood sugar by stimulating the pancreas to produce more insulin and has shown continual success in patients with lowering their A1-C. The introduction of medications such as Ozempic and Wegovy has changed the game for millions of people worldwide who have been struggling with diabetes. It was a once weekly auto injector that would allow patients to maintain their sugar levels and create a healthier way of life. One of its known side effects, however, was dramatic weight loss.
In early 2022, Ozempic rose to fame when celebrities who do not suffer from diabetes began publicizing the drugs’ ability to assist in fast acting weight loss. It quickly went from a lifesaving medication for diabetics to the celebrity go to for shedding unwanted pounds. In 2021, in the U.S. alone, prescriptions of the drug quadrupled landing the miracle drug on the worldwide shortage list creating rippling effects through many communities.
Valentine Paterson of Brooklyn, New York thought he had found a solution to his endless battle with obesity and diabetes when he was prescribed Ozempic. The effects were almost immediate and life altering. “I weighed more than 365 pounds and after being hospitalized for heart failure, my doctor recommended I take Ozempic,” said Paterson a 52-year-old Uber driver. “Within four months of taking the drug, I lost 65 pounds, and my doctor reduced my other medications from nine to four. It changed my life. But then I could not get my prescription filled. I looked for months; it was a nightmare. All the work and progress I was making was slipping away, all because I was unable to pay out of pocket.”
The reason Mr. Paterson could not get his prescription filled is because Mr. Paterson’s local pharmacy, like many others nationwide, was no longer able to obtain the blockbuster medication. The craze of Ozempic and Wegovy created a nationwide shortage of medication by those willing to pay the exorbitant out-of-pocket costs getting first cracks at the available supply. So, while pharmacies in lower income neighborhoods could not stock their shelves, pharmacies on Manhattan’s Upper Eastside had a twelve-month supply of the miracle drug readily available to those able to pay $1,400.00 per prescription. Given this void, the question was raised as to whether anyone or anything could help.
Enter the compounding pharmacy. According to the FDA, compounding pharmacies are authorized to produce exact drugs in times of a national shortage. But what exactly is a compounding pharmacy? A compounding pharmacy makes and sells prescription medicines based on the specific formula provided to it by the FDA. When a medicine makes its way to the national shortage list, compounding pharmacies are authorized to make generic versions of those medications to assist all those in need. When a medicine is not on the national shortage list, compounding pharmacies are only authorized to make alternate forms of the prescribed drug. Ozempic has been on both the worldwide and US shortage list since April of 2022. However, what happens when Big Pharma doesn’t want to let compounding pharmacies earn money they feel belongs to them even during a shortage?
“Lifeline Pharmacy” is a small compounding pharmacy run by Dr. Aisha Johnson in the heart of south Los Angeles. For years, this pharmacy has served as a beacon of hope, providing personalized care and essential medications to the predominantly Black and Latino residents. Among the most critical medications Dr. Johnson compounds is semaglutide, the active ingredient in Ozempic and Wegovy. According to the US Department of Health and Human Services, Black adults are nearly twice as likely as white adults to develop type 2 diabetes. This racial disparity has been rising over the last 30 years creating a disproportionate need for these life altering medications in communities of color. Despite the FDA’s approval for compounding pharmacies to produce semaglutide, Novo Nordisk has targeted these providers in order to protect their profits and eliminate the competition.
In the Ward 8 area of Washington, D.C., a heavily populated community of Black and Latino residents, the drug remains in high demand with little to no supply. “There is definitely a monopoly on it by Big Pharma,” said Dr. Damon Ricks, Pharmacy Manager at SIP. “Small Compounding Pharmacies are definitely within their rights and scope to create these drugs when the FDA declares a shortage.”
The impact of Big Pharma’s campaign is being felt in communities from Brooklyn, NY to Los Angeles, CA. The misinformation spread by Novo Nordisk, stating that compounded versions of semagludies are unsafe and potentially life threating has created fear and uncertainty in those using compounded versions of the popular medication. Intensifying the problem, legislative proposals influenced by pharmaceutical lobbyists threatened to impose restrictions that would make it nearly impossible for small pharmacies to continue compounding semaglutide. For communities of color, this means losing a critical source of affordable and accessible medication.
“Big Pharma should not have a hold on these drugs. There needs to be a leveling of the playing field. I think having access to these drugs all across the board is needed. If a patient needs it for diabetes, then it should be made available to them. Prioritizing weight loss over diabetic patients is an injustice to our health care system,” said Ricks.
But Big Pharma continues to push for stricter regulations, claiming the need for patient safety. However, insufficient evidence exists to back up any of the claims made by Big Pharma. Compounding pharmacies must comply with existing rigorous standards to make any medication. They follow these standards in order to serve lower economic depressed communities of color. The popularity of these drugs has made it difficult for average Americans to afford or find these medications. These are not just weight loss medications; they are tools for survival for many diabetic patients. Due to Big Pharma’s bullying campaign, many patients have been forced to accept lower doses of these drugs to maintain any benefits even though most experience little to no progress with the reduced dosage. Yet those that truly need these lifesaving medications continue to suffer.
For communities of color, the ability of local compounding pharmacies to provide semaglutide and other essential medications is about more than access to treatment. They serve as a testament to the power of community and the relentless pursuit of a more just and equitable healthcare system.
The post Drug Used to Treat Diabetes Now a Weight Loss Miracle but Difficult to Obtain in Black and Brown Communities first appeared on BlackPressUSA.
#NNPA BlackPress
Trump Set to Sign Largest Cut to Medicaid After a Marathon Protest Speech by Leader Jeffries
BLACKPRESSUSA NEWSWIRE — The bill also represents the biggest cut in Medicare in history and is a threat to the health care coverage of over 15 million people. The spending in Trump’s signature legislation also opens the door to a second era of over-incarceration in the U.S.

By Lauren Burke
By a vote of 218 to 214, the GOP-controlled U.S. House passed President Trump’s massive budget and spending bill that will add $3.5 trillion to the national debt, according to the Congressional Budget Office (CBO). The bill also represents the biggest cut in Medicare in history and is a threat to the health care coverage of over 15 million people. The spending in Trump’s signature legislation also opens the door to a second era of over-incarceration in the U.S. With $175 billion allocated in spending for immigration enforcement, the money for more police officers eclipsed the 2026 budget for the U.S. Marines, which is $57 billion. Almost all of the policy focus from the Trump Administration has focused on deporting immigrants of color from Mexico and Haiti.
The vote occurred as members were pressed to complete their work before the arbitrary deadline of the July 4 holiday set by President Trump. It also occurred after Democratic Leader Hakeem Jeffries took the House floor for over 8 hours in protest. Leader Jeffries broke the record in the U.S. House for the longest floor speech in history on the House floor. The Senate passed the bill days before and was tied at 50-50, with Republican Senator Lisa Murkowski saying that, “my hope is that the House is gonna look at this and recognize that we’re not there yet.” There were no changes made to the Senate bill by the House. A series of overnight phone calls to Republicans voting against, not changes, was what won over enough Republicans to pass the legislation, even though it adds trillions to the debt. The Trump spending bill also cuts money to Pell grants.
“The Big Ugly Bill steals food out of the hands of starving children, steals medicine from the cabinets of cancer patients, and equips ICE with more funding and more weapons of war than the United States Marine Corps. Is there any question of who those agents will be going to war for, or who they will be going to war against? Beyond these sadistic provisions, Republicans just voted nearly unanimously to close urban and rural hospitals, cripple the child tax credit, and to top it all off, add $3.3 trillion to the ticking time bomb that is the federal deficit – all from a party that embarrassingly pretends to stand for fiscal responsibility and lowering costs,” wrote Congressional Black Caucus Chairwoman Yvette Clarke (D-NY) in a statement on July 3.
“The Congressional Budget Office predicts that 17 million people will lose their health insurance, including over 322,000 Virginians. It will make college less affordable. Three million people will lose access to food assistance through the Supplemental Nutrition Assistance Program (SNAP). And up to 16 million students could lose access to free school meals. The Republican bill does all of this to fund tax breaks for millionaires, billionaires, and corporations,” wrote Education and Workforce Committee ranking member Rep. Bobby Scott (D-VA) in a statement. The bill’s passage has prompted Democrats to start thinking about 2026 and the next election cycle. With the margins of victory in the U.S. House and U.S. Senate being so narrow, many are convinced that the balance of power and the question of millions being able to enjoy health care come down to only several thousand votes in congressional elections. But currently, Republicans controlled by the MAGA movement control all three branches of government. That reality was never made more stark and more clear than the last seven days of activity in the U.S. House and U.S. Senate.

#NNPA BlackPress
Congressional Black Caucus Challenges Target on Diversity
BLACKPRESSUSA NEWSWIRE — we found that the explanations offered by the leadership of the Target Corporation fell woefully short of what our communities deserve and of the values of inclusion that Target once touted

By Stacy M. Brown
Black Press USA Senior National Correspondent
Target is grappling with worsening financial and reputational fallout as the national selective buying and public education program launched by the Black Press of America and other national and local leaders continues to erode the retailer’s sales and foot traffic. But a recent meeting that the retailer intended to keep quiet between CEO Brian Cornell and members of the Congressional Black Caucus Diversity Task Force was publicly reported after the Black Press discovered the session, and the CBC later put Target on blast.
“The Congressional Black Caucus met with the leadership of the Target Corporation on Capitol Hill to directly address deep concerns about the impact of the company’s unconscionable decision to end a number of its diversity, equity, and inclusion efforts,” CBC Chair Yvette Clarke stated. “Like many of the coalition leaders and partner organizations that have chosen to boycott their stores across the country, we found that the explanations offered by the leadership of the Target Corporation fell woefully short of what our communities deserve and of the values of inclusion that Target once touted,” Congresswoman emphasized. “Black consumers contribute overwhelmingly to our economy and the Target Corporation’s bottom line. Our communities deserve to shop at businesses that publicly share our values without sacrificing our dignity. It is no longer acceptable to deliver promises to our communities in private without also demonstrating those values publicly.”
Lauren Burke, Capitol Hill correspondent for Black Press of America, was present when Target CEO Cornell and a contingent of Target officials arrived at the U.S. Capitol last month. “It’s always helpful to have meetings like this and get some candid feedback and continue to evolve our thinking,” Cornell told Burke as he exited the meeting. And walked down a long hallway in the Cannon House Office Building. “We look forward to follow-up conversations,” he stated. When asked if the issue of the ongoing boycott was discussed, Cornell’s response was, “That was not a big area of focus — we’re focused on running a great business each and every day. Take care of our teams. Take care of the guests who shop with us and do the right things in our communities.”
A national public education campaign on Target, spearheaded by Dr. Benjamin F. Chavis Jr., president and CEO of the National Newspaper Publishers Association (NNPA), the NNPA’s board of directors, and with other national African American leaders, has combined consumer education efforts with a call for selective buying. The NNPA is a trade association that represents the more than 220 African American-owned newspapers and media companies known as the Black Press of America, the voice of 50 million African Americans across the nation. The coalition has requested that Target restore and expand its stated commitment to do business with local community-owned businesses inclusive of the Black Press of America, and to significantly increase investment in Black-owned businesses and media, Historically Black Colleges and Universities (HBCU, Black-owned Banks, national Black Church denominations, and grassroots and local organizations committed to improving the quality of life of all Americans, and especially those from underserved communities. According to Target’s latest earnings report, net sales for the first quarter of 2025 fell 2.8 percent to $23.85 billion compared to the same period last year. Comparable store sales dropped 3.8 percent, and in-store foot traffic slid 5.7 percent.
Shares of Target have also struggled under the pressure. The company’s stock traded around $103.85 early Wednesday afternoon, down significantly from roughly $145 before the controversy escalated. Analysts note that Target has lost more than $12 billion in market value since the beginning of the year. “We will continue to inform and to mobilize Black consumers in every state in the United States,” Chavis said. “Target today has a profound opportunity to respond with respect and restorative commitment.”
-
Activism4 weeks ago
Oak Temple Hill Hosts Interfaith Leaders from Across the Bay Area
-
Alameda County4 weeks ago
Council Approves Budget to Invest in Core City Services, Save Fire Stations, Invest in Economic Development
-
Activism4 weeks ago
Oakland Post: Week of June 11 – 17, 2025
-
Activism4 weeks ago
LA to the Bay: Thousands Protest in Mission District Against Immigration Raids, Travel Bans
-
Activism4 weeks ago
Over 500 Join Interfaith Rally in Solidarity with Los Angeles Resistance to Trump Invasion
-
Activism3 weeks ago
OPINION: California’s Legislature Has the Wrong Prescription for the Affordability Crisis — Gov. Newsom’s Plan Hits the Mark
-
Activism3 weeks ago
Congress Says Yes to Rep. Simon’s Disability Hiring and Small Biz Support Bill
-
Activism3 weeks ago
The Case Against Probate: False Ruling Invalidates Black Professor’s Estate Plan, Ignoring 28-Year Relationship